Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 10/20 | 1.00 |
| ▸ | HSD11B2 | P80365 | 9/20 | 1.00 |
| ▸ | CES2 | O00748 | 5/20 | 1.00 |
| ▸ | CES1 | P23141 | 5/20 | 1.00 |
| ▸ | PTPN1 | P18031 | 3/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | MAPT | P10636 | 2/20 | 1.00 |
| ▸ | ALOX5 | P09917 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | AKR1B10 | O60218 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | PRKCH | P24723 | 1/20 | 1.00 |
| ▸ | PTPN6 | P29350 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | PTPN11 | Q06124 | 1/20 | 1.00 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 1.00 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.76 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.76 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Enoxolone SCHEMBL15448799 | 1.00 | HSD11B1 (1.00) | HSD11B1HSD11B2CES2CES1PTPN1 | |
| Enoxolone SCHEMBL11891060 | 1.00 | HSD11B1 (1.00) | HSD11B1HSD11B2CES2CES1PTPN1 | |
| Enoxolone SCHEMBL13382933 | 1.00 | HSD11B1 (1.00) | HSD11B1HSD11B2CES2CES1PTPN1 | |
| Enoxolone SCHEMBL2762655 | 1.00 | HSD11B1 (1.00) | HSD11B1HSD11B2CES2CES1PTPN1 | |
| Enoxolone SCHEMBL23016683 | 1.00 | HSD11B1 (1.00) | HSD11B1HSD11B2CES2CES1PTPN1 | |
| Enoxolone SCHEMBL25465 | 1.00 | HSD11B1 (1.00) | HSD11B1HSD11B2CES2CES1PTPN1 | |
| Enoxolone SCHEMBL23252837 | 1.00 | HSD11B1 (1.00) | HSD11B1HSD11B2CES2CES1PTPN1 | |
| Enoxolone SCHEMBL2762929 | 1.00 | HSD11B1 (1.00) | HSD11B1HSD11B2CES2CES1PTPN1 | |
| Enoxolone SCHEMBL6544340 | 1.00 | HSD11B1 (1.00) | HSD11B1HSD11B2CES2CES1PTPN1 | |
| Enoxolone SCHEMBL231125 | 1.00 | HSD11B1 (1.00) | HSD11B1HSD11B2CES2CES1PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220296544-A1 | NANOEMULSION OF 18BETA-GLYCYRRHETINIC ACID | PROYECTOS ATSO S.A.P.I. DE C.V. (MX) | 2022-09-22 | — | — | US | disclosed |
| EP-4023219-A1 | NANOEMULSION OF 18BETA-GLYCYRRHETINIC ACID | Atso Corporate Affairs, S.A. De C.V. (MX) | 2022-07-06 | — | — | EP | disclosed |
| EP-2633887-A1 | Novel agent combination for efficient anti-wrinkle effect | Henkel AG&Co. KGAA (DE) | 2013-09-04 | — | — | EP | disclosed |
| US-20080045594-A1 | Use of at Least One Conjugated Triene-Containing Fatty Acid for Preparing a Medicine for Treating Inflammation | LABORATOIRES EXPANSCIENCE (FR) | 2008-02-21 | — | — | US | disclosed |
| EP-0847279-B1 | ANTIPRURIGINOUS COSMETIC AND/OR PHARMACEUTICAL COMPOSITIONS CONSISTING OF ONE OR SEVERAL LIGHT LOCAL ANAESTHETICS AND ONE OR SEVERAL ASTRINGENT SUBSTANCES | BAYER AG (DE) | 2002-05-02 | — | — | EP | disclosed |
| US-6217885-B1 | SKIN DISORDERS; THERAPY FOR INSECT BITES | BAYER AKTIENGESELLSCHAFT (DE) | 2001-04-17 | — | — | US | disclosed |
| US-5425948-A | Contains 18beta-glycyrretic acid, extract of sanguinaria, and a metallic salt | KEMIPROGRESS S.R.L. (IT) | 1995-06-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080045594-A1 | Use of at Least One Conjugated Triene-Containing Fatty Acid for Preparing a Medicine for Treating Inflammation | FASN, CYP46A1, PPARG | HSD11B1 132/4885HSD11B2 340/4885CES2 392/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.